Hospital Mutua de Terrassa

Terrassa, Catalonia 08221

0 studies enrolling now · 5 studies all time

What they study most

Acute Kidney Injury, Colorectal Cancer, Ovarian Cancer, Severe Sepsis

Studies at this site

• Efficacy and Safety of Farletuzumab (MORAb-003) in Combination With Carboplatin and Taxane in Participants With Platinum-sensitive Ovarian Cancer in First Relapse — Stopped early
• A Safety, Tolerability, Efficacy and QoL Study of Human recAP in the Treatment of Patients With SA-AKI — Completed
• A Study Combining mFOLFOX6 With Tivozanib or Bevacizumab in Patients With Metastatic Colorectal Cancer as First Line Therapy — Completed
• Safety and Efficacy of Talactoferrin Alfa in Patients With Severe Sepsis — Paused
• Safety and Efficacy Study of Recombinant Human Lactoferrin to Treat Severe Sepsis — Completed